Mesenchymal Chondrosarcoma
Mesenchymal chondrosarcoma is a rare type of cancer that primarily affects cartilage and bone, often presenting as a painful mass. It can occur in various locations in the body and may metastasize to other areas.
Trabectedin for HEY1-NOCA2 Positive Mesenchymal Chondrosarcoma
We are studying the effects of trabectedin in adults and young adults with advanced mesenchymal chondrosarcoma who have already received other treatments. The trial aims to assess how well this medication works in reducing tumors and improving patient outcomes.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 16 years old?
- Are you currently pregnant or breastfeeding?
- Do you have any serious heart problems, like congestive heart failure or a heart attack in the last 6 months?
- Have you had any major bleeding events in the last 4 weeks?
- Do you have chronic liver disease, like hepatitis or cirrhosis?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Trabectedin
Trabectedin
Trabectedin Accord
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Istituto Di Candiolo Fondazione Del Piemonte Per Loncologia IRCCS
Oncologia Medica
Airali, Italy
Istituto Ortopedico Rizzoli
SSD chemioterapia dei tumori dell'apparato musscolo scheletrico
Bologna, Italy
Istituto Nazionale Dei Tumori
SC Tumori Mesenchimali e tumori rari dell'adulto
Milan, Italy
Sponsor: Italian Sarcoma Group
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.